CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Shares withheld for taxes Chief Accounting Officer gave up 536 shares (to pay taxes)
- 4 Open-market sale Sr. VP & Chief Comm. Officer sold 8,000 shares at $14.11 ($112,840)
- 4 Open-market sale Sr. VP & Chief Scientific Off. sold 8,504 shares at $14.12 ($120,080)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP and CFO sold 5,808 shares at $14.40 ($83,623)
- 4 Open-market sale Sr. VP & Chief Comm. Officer sold 8,000 shares at $14.40 ($115,202)
- 4 Shares withheld for taxes Sr. VP & Chief Scientific Off. gave up 3,089 shares (to pay taxes)
- 4 Grant or award Director acquired 14,249 shares (grant or award)
- 4 Grant or award Director acquired 14,249 shares (grant or award)
- 4 Grant or award Director acquired 14,249 shares (grant or award)
- 4 Grant or award Director acquired 14,249 shares (grant or award)
- 4 Grant or award Director acquired 14,249 shares (grant or award)
- 4 Grant or award Interim PEO, SVP and CFO acquired 93,056 shares (grant or award)
- 4 Grant or award Sr. VP & Chief Comm. Officer acquired 74,444 shares (grant or award)
- 4 Grant or award Sr. VP & Chief Scientific Off. acquired 74,444 shares (grant or award)
- 4 Open-market sale Interim PEO, SVP and CFO sold 5,378 shares at $16.52 ($88,825)
- 4 Open-market sale Sr. VP & Chief Scientific Off. sold 9,890 shares at $16.60 ($164,148)
- 4 Open-market sale Sr. VP & Chief Comm. Officer sold 8,000 shares at $16.51 ($132,100)
- 4 Grant or award Director acquired 10,517 shares (grant or award)
Page 9 of 39 · 776 filings